A really inspiring development in the digital therapeutics sphere with the FDA approving a video based game as a prescription treatment for ADHD. It will be really interesting to see, especially in a post-Covid world, how tech solutions are able to help us in more diverse ways - and how both big tech and more traditional healthcare companies will adjust and potentially collaborate.
| less than a minute read
FDA approve video game as a clinical treatment
Akili today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD). Delivered through a captivating video game experience, EndeavorRx is indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue.